Articles / Does AHPRA need to be reined in…or struck off?
AHPRA used its ‘naming and shaming’ powers for the first time this week, against a suspended WA practitioner who had previously been registered as both a dentist and nurse, but who had continued to practise despite his suspension.
The Dental Board said the practitioner remains under investigation and is facing criminal charges to which he is pleading not guilty.
Dr Mukesh Haikerwal, a GP advocate and former AMA president, says the legislation which allows for practitioners to be publicly named while investigation is still ongoing is illogical. While it may be justified once the investigation has determined errant practice, he contends that the investigation should be complete before taking actions that will besmirch someone’s reputation.
“The name and shame provisions, whilst pending outcomes, really flies in the face of normal legal process,” Dr Haikerwal says. “Just because you’re medically qualified or you’re a registered health professional doesn’t remove your legal rights and your human rights.”
The move comes as we await recommendations following an investigation into AHPRA’s use of immediate action against health professionals. Key players including the AMA, RACGP, Australian GP Alliance and Avant have all released submissions arguing that greater safeguards are needed.
The concerns of the peak bodies and medical defence organisation reflect that of a majority of GPs, a Healthed survey of more than 2000 GPs suggests.
Sixty-three percent of GPs said the current checks and balances on AHPRA’s powers need improvement, with more than a third strongly agreeing with that statement.
Australian Doctors Federation chair and GP Clinical Associate Professor Aniello Iannuzzi said those results were likely an under-representation of doctors’ concerns.
“I find that as soon as AHPRA’s mentioned, such is the deep-seated fear, that doctors will not reply or reply more favourably than they feel because they are so petrified that they’re going to be targeted,” he said. “So I think there’s a bias there.”
Dr Haikerwal says we are at a turning point with a new CEO of AHPRA and new chair of the Medical Board, but as yet nothing has changed.
“Ultimately, we need regulatory agencies to look after the registration and management of the professions. But I think there needs to be a whole reset, if not a complete detonation and restart,” he says.
“You can either destroy it and start again, or you can try and make adjustments. There has to be significant changes made. And this survey has really highlighted it,” Dr Haikerwal says.
“It’s a totally headless organisation.”
If AHPRA is going to be repaired, Dr Haikerwal says good consultation processes, with respectful, meaningful engagement, are essential. Has that process begun?
“No, they’re indicating they might, but nothing’s happened. It’s all weasel words just now.”
Part of the problem, he says, is that despite claims otherwise, the legislation is not consistent across states or territories. “And each of the health ministers runs for the hills when there’s a problem.”
Despite numerous reviews and inquiries, no useful change has been achieved.
“AHPRA get everything that they ask for when they go to governments for increased power — and they never ask to modify or improve the situation for the registrants who they depend on for their funding,” Dr Haikerwal sums up.
GPs in Healthed’s survey commented anonymously, with several noting lack of transparency and lack of accountability and oversight as cause for concern:
Insomnia – Drug & Non-Drug Management
Lung Cancer Screening Has Started – What GPs Need to Know
Continuous Glucose Monitoring (CGM) for Diabetes Management in GP
Menopausal Hot Flushes Management
Within the next 12 months
Within the next 3 years
Within the next 5 years
Within the next 10 years
More than 10 years
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease